Gsk (GSK) Change in Inventory (2009 - 2023)
Gsk (GSK) posted Change in Inventory of -$526.2 million for Q4 2023, down 66.79% quarter-over-quarter from -$315.5 million in Q4 2022, and down 66.79% YoY from -$1.6 billion in Q4 2022.
Powered by 
Analysis
Gsk (GSK) Change in Inventory (2009 - 2023) Analysis & Trends
Gsk (GSK) has 10 years of Change in Inventory data on file, last reported at -$526.2 million in Q4 2023.
- For the quarter ending Q4 2023, Change in Inventory fell 66.79% year-over-year to -$526.2 million; the trailing twelve-month figure through Dec 2023 stood at -$1.6 billion (up 16.13% YoY), and the FY2023 full-year result was -$527.4 million, down 58.41% from the prior year.
- Change in Inventory was -$526.2 million for Q4 2023 at Gsk, down from -$315.5 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of -$315.5 million in Q4 2022 to a low of -$526.2 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Asml Holding | 618.86 Bn | 602.88 Bn | 5.90 Bn | - |
| 2 | Hsbc Holdings | 361.40 Bn | 361.40 Bn | - | - |
| 3 | General Electric | 329.38 Bn | 320.03 Bn | 6.95 Bn | 109.00 Mn |
| 4 | Astrazeneca | 253.73 Bn | 248.44 Bn | 12.86 Bn | - |
| 5 | Citigroup | 228.07 Bn | -2,074.24 Bn | 24.75 Bn | - |
| 6 | Bhp | 216.09 Bn | 197.55 Bn | - | - |
| 7 | Rio Tinto | 203.71 Bn | 199.33 Bn | - | - |
| 8 | Diageo | 197.36 Bn | 195.32 Bn | - | - |
| 9 | Unilever | 139.15 Bn | 132.12 Bn | - | - |
| 10 | Gsk | 101.53 Bn | 101.53 Bn | 15.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | -526.25 Mn |
| Dec 31, 2022 | -315.52 Mn |
| Dec 31, 2017 | -612.05 Mn |
| Dec 31, 2015 | -168.44 Mn |
| Dec 31, 2014 | -838.15 Mn |
| Dec 31, 2013 | 153.81 Mn |
| Dec 31, 2012 | 59.42 Mn |
| Dec 31, 2011 | -246.74 Mn |
| Dec 31, 2010 | 376.01 Mn |
| Dec 31, 2009 | -215.62 Mn |